Key Points
- Proto Labs CFO Daniel Schumacher sold 5,000 shares at an average price of $95.32, totaling $476,600. The Rule 10b5-1 plan transaction reduced his ownership by 12.49%, leaving him with 35,019 shares.
- Proto Labs reported quarterly EPS of $0.60, beating estimates of $0.53, while revenue rose 10.5% year over year to $149.34 million. The stock opened at $96.19 and was near its 52-week high.
- Analysts maintain a consensus “Buy” rating with an average price target of $89, while institutional investors own approximately 84.54% of the company’s shares.
Proto Labs, Inc. (NYSE:PRLB - Get Free Report) CFO Daniel Schumacher sold 5,000 shares of the business's stock in a transaction on Thursday, September 24th. The shares were sold at an average price of $95.32, for a total value of $476,600.00. Following the sale, the chief financial officer owned 35,019 shares in the company, valued at approximately $3,338,011.08. The trade was a 12.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Daniel Schumacher also recently made the following trade(s):
- On Thursday, September 17th, Daniel Schumacher sold 4,900 shares of Proto Labs stock. The stock was sold at an average price of $85.21, for a total value of $417,529.00.
- On Wednesday, September 16th, Daniel Schumacher sold 100 shares of Proto Labs stock. The stock was sold at an average price of $85.00, for a total value of $8,500.00.
Proto Labs Stock Up 3.5%
Shares of NYSE PRLB opened at $96.19 on Friday. The company has a market cap of $2.30 billion, a P/E ratio of 76.95 and a beta of 1.42. Proto Labs, Inc. has a 52 week low of $45.10 and a 52 week high of $96.92. The business has a 50-day simple moving average of $82.85 and a two-hundred day simple moving average of $73.70.
Proto Labs (NYSE:PRLB - Get Free Report) last announced its quarterly earnings results on Friday, July 31st. The industrial products company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.53 by $0.07. Proto Labs had a return on equity of 4.80% and a net margin of 5.44%.The firm had revenue of $149.34 million for the quarter, compared to analysts' expectations of $144.53 million. During the same period in the prior year, the business posted $0.41 earnings per share. The company's revenue was up 10.5% on a year-over-year basis. Proto Labs has set its Q3 2026 guidance at 0.560-0.640 EPS. Equities research analysts anticipate that Proto Labs, Inc. will post 1.46 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on PRLB. Needham & Company LLC raised shares of Proto Labs from a "hold" rating to a "buy" rating and set a $87.00 target price on the stock in a report on Monday, August 3rd. Benchmark raised their price target on shares of Proto Labs from $70.00 to $91.00 and gave the company a "buy" rating in a report on Thursday, July 2nd. Weiss Ratings lowered shares of Proto Labs from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, September 18th. Zacks Research raised shares of Proto Labs from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 6th. Finally, Wall Street Zen downgraded Proto Labs from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 18th. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $89.00.
Check Out Our Latest Report on PRLB
Hedge Funds Weigh In On Proto Labs
Large investors have recently added to or reduced their stakes in the business. Engineers Gate Manager LP boosted its position in Proto Labs by 84.7% during the second quarter. Engineers Gate Manager LP now owns 26,780 shares of the industrial products company's stock valued at $2,183,000 after buying an additional 12,280 shares during the period. Corient Private Wealth LP increased its holdings in shares of Proto Labs by 16.1% in the second quarter. Corient Private Wealth LP now owns 12,427 shares of the industrial products company's stock worth $1,013,000 after buying an additional 1,723 shares during the period. Angeles Wealth Management LLC increased its holdings in shares of Proto Labs by 12.4% in the second quarter. Angeles Wealth Management LLC now owns 5,045 shares of the industrial products company's stock worth $411,000 after buying an additional 555 shares during the period. Turner Financial Group Inc. bought a new stake in shares of Proto Labs in the 2nd quarter valued at about $395,000. Finally, Susquehanna Fundamental Investments LLC lifted its stake in shares of Proto Labs by 227.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 33,760 shares of the industrial products company's stock valued at $2,752,000 after acquiring an additional 23,435 shares during the last quarter. Hedge funds and other institutional investors own 84.54% of the company's stock.
Proto Labs Company Profile
(
Get Free Report)
Proto Labs, Inc (NYSE: PRLB), doing business as Protolabs, is a digital manufacturing company that provides rapid prototyping and on-demand production services. Its platform enables engineers and product developers to upload three-dimensional computer-aided design files, receive automated design analyses and quotes, and order custom parts through a streamlined online process.
The company offers computer numerical control machining, injection molding, 3D printing and sheet-metal fabrication.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
